2016
How to Use Type 2 Diabetes Treatments in Clinical Practice: Combination Therapies
Inzucchi S, Matthews D. How to Use Type 2 Diabetes Treatments in Clinical Practice: Combination Therapies. 2016, 471-492. DOI: 10.1002/9781118924853.ch33.Peer-Reviewed Original ResearchType 2 diabetesMultiple pathophysiological defectsGlucose-lowering agentsSide effect profileAmerican Diabetes AssociationRecent position statementStudy of DiabetesMechanism of actionComplementary regimensManagement of peopleDiabetes AssociationCombination therapyPathophysiological defectsAntihyperglycemic agentsDrug therapyClinical practiceType 2Clinical useEuropean AssociationDiabetesIndividual riskPosition statementTherapyAssociationRegimens
2012
Erratum to: Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Inzucchi S, Bergenstal R, Buse J, Diamant M, Ferrannini E, Nauck M, Peters A, Tsapas A, Wender R, Matthews D. Erratum to: Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2012, 56: 680-680. DOI: 10.1007/s00125-012-2785-9.Peer-Reviewed Original ResearchManagement of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Inzucchi S, Bergenstal R, Buse J, Diamant M, Ferrannini E, Nauck M, Peters A, Tsapas A, Wender R, Matthews D. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2012, 55: 1577-1596. PMID: 22526604, DOI: 10.1007/s00125-012-2534-0.Peer-Reviewed Original Research